QuidelOrtho Corp

QuidelOrtho’s insider equity grant signals management confidence amid earnings pressure, hinting at future growth while raising dilution and volatility concerns for investors.

Insider buys at QuidelOrtho reveal exec confidence in its R&D pipeline—and hint at possible share‑repurchase plans, despite negative earnings and stiff competition.